Dermapharm Holding SE
DMPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,224,123 | $2,078,903 | $2,146,001 | $2,020,766 |
| - Cash | $121,195 | $158,724 | $149,918 | $160,319 |
| + Debt | $979,612 | $1,080,388 | $516,448 | $580,301 |
| Enterprise Value | $3,082,540 | $3,000,567 | $2,512,531 | $2,440,748 |
| Revenue | $1,180,766 | $1,150,741 | $1,024,776 | $942,912 |
| % Growth | 2.6% | 12.3% | 8.7% | – |
| Gross Profit | $767,070 | $704,144 | $660,833 | $620,694 |
| % Margin | 65% | 61.2% | 64.5% | 65.8% |
| EBITDA | $320,908 | $262,737 | $323,544 | $356,973 |
| % Margin | 27.2% | 22.8% | 31.6% | 37.9% |
| Net Income | $113,787 | $62,368 | $134,236 | $209,583 |
| % Margin | 9.6% | 5.4% | 13.1% | 22.2% |
| EPS Diluted | 2.11 | 1.16 | 2.49 | 3.89 |
| % Growth | 81.9% | -53.4% | -36% | – |
| Operating Cash Flow | $201,378 | $219,422 | $288,533 | $250,368 |
| Capital Expenditures | -$38,237 | -$41,541 | -$39,014 | -$61,203 |
| Free Cash Flow | $163,141 | $177,881 | $249,519 | $189,165 |